Recently, Nakamura et al (21) demonstrated that metformin reduces the expression of Shh in pancreatic cancer cells, suggesting that the suppression of Shh signaling is a possible mechanism through which metformin mediates its anticancer effects. The gene discussed is SHH; the disease is pancreatic neoplasm.